The Department of Health has insisted there will be no "material change" to the UK's preparations for swine flu. The …
Government anti-smoking measures are to receive a boost with the provision of a £2.5 million grant to help smokers kick …

The deal gives the Roche-owned biotech development and marketing rights to Bayhill’s molecule BHT-3021, which is currently in phase I/II …
The big pharma model is broken, and one of the ways drug development companies are going to fix it is …
The NHS is hurtling towards the most severe financial shortfall of its history, and faces an austere future of cutting …
Contract research organisation Kendle has opened up new offices in Malaysia, Thailand and the Philippines as part of a continued …
Despite the pharmaceutical industry's evolving business model in response to growing regulatory constraints, the sector is facing unprecedented challenges caused …
Sanofi-Aventis will pay 30 million euros (£26 million) for a manufacturing plant in Germany operated by Pfizer in a deal …
The Pharmaceutical Marketing Society is to showcase the best in digital media across the pharma and healthcare industry at a …
GlaxoSmithKline has chosen new agencies to handle some of it biggest consumer brands, including Nicorette and weight loss drug Alli. …
Market Research and analytics is an area which continues to present new challenges and opportunities for our industry. I first …
Andy Burnham has been named as the government's new secretary of state for health, in Prime Minister Gordon Brown's latest …
AstraZeneca is putting more than £4 million over the next three years into an oncology research project with two partners. …
The funding crisis which is paralysing the global biotech sector sees no sign of abating, and more and more companies …
The former managing director of GCI Health has set up a communications agency aimed at pharma companies and other healthcare …
People from across the industry are being asked to volunteer as 'ambassadors' for the pharma sector to conduct a large-scale …
Funding worth £2 million has been made available for research into how NICE can better do its job. The drug …